Related Experiment Video
Updated: Apr 28, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
[Research progress on artemisinin and its derivatives in treatment of orthopedics-related diseases]
Xiao-Tian Feng1, Jian-Xiong Ma2, Yan Wang2
1Tianjin Hospital, Tianjin University (Tianjin Hospital) Tianjin 300211, China Tianjin Institute of Orthopedics Tianjin 300050, China Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering Tianjin 300050, China School of Integrated Medicine, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Abstract:
As research into the mechanisms of orthopedic diseases continues to deepen, the shortcomings of traditional single-target the-rapies are becoming increasingly apparent. Consequently, the search for multi-target drugs has become the mainstream research direction for orthopedics-related diseases. Artemisinin, a sesquiterpene lactone compound extracted from Artemisia annua, has led to the gradual synthesis of various derivatives such as dihydroartemisinin, artesunate, artemether, and arteether. Recent pharmacological studies have found that artemisinin and its derivatives can treat osteoporosis, osteoarthritis, rheumatoid arthritis, osteosarcoma, and other orthopedic diseases by regulating osteoblast-osteoclast coupling, modulating immune response, inhibiting angiogenesis, protecting cartilage, and inhibiting tumor growth. This paper reviewed the metabolic characteristics and mechanisms of action of artemisinin and its derivatives in the treatment of orthopedic diseases, aiming to inspire modern research on artemisinin-based drugs and orthopedic diseases.
More Related Videos
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care

